<i>Pseudomonas aeruginosa</i>infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approachesHelena Lund‐Palau, Jane C. Davies, A R Turnbull et al.|Expert Review of Respiratory Medicine|2016Cited by 170
Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosisWynne D. Smith, Jane C. Davies, Emmanuelle Bardin et al.|FEMS Microbiology Letters|2017Cited by 107
Modulators of CFTR. Updates on clinical development and future directionsEmmanuelle Bardin, Isabelle Sermet‐Gaudelus, Farouk Berhal et al.|European Journal of Medicinal Chemistry|2021Cited by 67
Metabolic Phenotyping and Strain Characterisation of Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients Using Rapid Evaporative Ionisation Mass SpectrometryEmmanuelle Bardin, Zoltán Takáts, Simon J. S. Cameron et al.|Scientific Reports|2018Cited by 33
Volatile metabolites differentiate air–liquid interface cultures after infection with <i>Staphylococcus aureus</i>Waqar Ahmed, Stephen J. Fowler, Emmanuelle Bardin et al.|The Analyst|2023Cited by 13